All News

A study assessed the reliability of a 12-gene Recurrence Score test to reveal the natural course of recurrence among Japanese patients with stage II and III colon cancer who have undergone surgery but not received any adjuvant chemotherapy.

Study’s findings add to concerns about health plans’ incentives not to comply with their legal obligation under the law to provide mental health benefits on par with medical and surgical benefits.

Groups seeking grants under the new program must show how they can train small practices without charging the doctors or their practices.

If the announcement by the Swiss pharmaceutical giant Novartis holds true, biosimilars that the company plans to launch over the next 4 years could create a significant dent in the sales of 5 blockbuster molecules in the oncology and immunology space.

The Affordable Care Act has helped many Americans gain access to health coverage, and a recent analysis from HHS discovered that rural America in particular has benefited.

The Affordable Care Act and additional legislation that has mandated extending mental health parity coverage are contributing to an increased demand for mental health services that the United States is not meeting.

What we're reading, June 20, 2016: employers are cutting back on wellness benefits; new apps and websites provide birth control prescriptions to women; and Novartis pledges to triple the number of biosimilar drugs on the market by 2020.

Researchers at the John Hopkins Bloomberg School of Public Health found that increases in unemployment in California during the Great Recession were associated with an increased risk for weight gain among 1.7 million public school children in the state.

The healthcare ecosystem can be a very complex place, and it’s important to remember that a patient sits at the center, explained David M. Cordani, president and CEO of Cigna Corp., during a general session on the second day of America’s Health Insurance Plans’ Institute & Expo.

Why this patient advocate is concerned about the newly proposed Medicare Part B model regarding its level of transparency and the evidence.

HHS recently signed a Memorandum of Understanding (MOU) with Cuba’s Public Ministry of Health on June 13, marking a historic moment for both countries since the re-establishment of diplomatic relations in 2015.

This week, the top stories in managed care included study results presented at the 76th Scientific Sessions of the American Diabetes Association from the SWITCH and LEADER trials, a recommendation for a smarter way to screen for prostate cancer, and researchers found physicians underutilize medications to treat opioid addiction.

Growing antibiotic resistance is a significant global problem. But steps are being taken to apply brakes on the rise of "superbugs."

Why this patient advocate is concerned about the newly proposed Medicare Part B model regarding its level of transparency and the evidence.

Delivering the results of complex genetic tests to at-risk patients over the telephone may be an effective way to reduce burdens and costs for patients with cancer or at risk for cancer and would not cause patients added stress, a study found.

The partnership will allow Medtronic to scale Canary Health's diabetes prevention programs to reach a wider audience and bring Canary's self-management platform into customer support for its devices.

An executive summary of the report on the PAN Foundation roundtable, presented with The American Journal of Managed Care, discussed the shift from the problem of the "uninsured" to the "underinsured."

What we're reading, June 17, 2016: California's insurance commissioner comes out in opposition of the merger between Anthem and Cigna; local governments push for drug makers to pay for drug take-back programs; and the CDC releases numbers of Zika-related birth defects in the United States.

As America’s Health Insurance Plans’ Institute & Expo kicked off in Las Vegas on June 15, Susan Dentzer, president and CEO of The Network for Excellence in Health Innovation, moderated a panel discussion on the possibility of delivery better healthcare at a lower cost.

Why this patient advocate is concerned about the newly proposed Medicare Part B model regarding its level of transparency and the evidence.

The new guideline, similar to the previous version, recommends screening for CRC for those 50 to 75 years of age and leaves the decision for screening in those 76 to 85 years of age on the individual. However, for the 50 to 75 age group, the USPSTF leaves the choice of the test on the individual, which is a departure from the previous guideline.

What we're reading, June 16, 2016: the federal government is encouraging state Medicaid programs to promote long-acting contraceptives; Congress introduces a bill the prevent drug makers from thwarting generic competition; and new recommendation that people can choose the type of colon cancer screening they receive.

Black women with BRCA gene mutations are far less likely to receive preventive surgery than white or Hispanic women with the BRCA gene mutation.

According to research published in the journal Clinical Cancer Research, immunotherapy right after chemotherapy can piggy back on the immune modifications caused by the chemotherapy, to improve response to treatment in ovarian cancer.

Healthcare providers are facing a syndrome called “EHR alert fatigue,” a product of the constant bombardment of health alerts on electronic health records (EHRs). How are providers and health systems reacting to this issue?

What we're reading, June 15, 2016: opioids also linked to heart-related deaths and fatalities other than overdoses; judge overrules Federal Trade Commission's efforts to block merger of Advocate Health Care and NorthShore University HealthSystem in Illinois; and using social media to monitor patients outside of the healthcare setting.

A collaborative effort by urologists and public health specialists from various healthcare systems around the country has found that PSA levels measured in midlife (45 to 59 years of age) are a strong predictor of future lethal prostate cancer.

Medicaid payments to hospitals comprise a large portion of a hospital’s finances; however, policy changes occurring under the Affordable Care Act may have several implications on the way hospitals receive payments from Medicaid.

A new study, published in the Journal of Thoracic Oncology, has found that chemotherapy administered in patients with stage I disease, following a complete resection, can have a significant impact on their median 5-year overall survival.